Findings seen in patients following myocardial infarction. (HealthDay News) — Beta-blocker treatment can lead to a modest increase in depressive symptoms among patients who have myocardial infarction ...

Researchers at the University of Virginia School of Medicine say this finding could open the door to better ways to manage ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

Findings seen for individuals undergoing revascularization after non-ST-segment elevation myocardial infarction ...

Following propensity score standardised mortality ratio weighting adjustment for 98 covariates, hazard ratios and rate ...

Left untreated, it increases risk of stroke, heart failure, myocardial infarction, chronic kidney disease and dementia.

Patients with congestive heart failure post-myocardial infarction plus hypertension with impaired renal function should be treated with caution. There are no well controlled studies of eplerenone ...

kidney problems and more. The goal of the BPROAD study was to determine whether an intensive systolic blood pressure ...

At AHA 2024, the safety of GLP-1R agonists in heart failure and chronic kidney disease (CKD) patients was discussed.

The best diabetes medication if you have kidney disease can vary by the severity of your kidney damage. You may need to use one that does not require dose adjustment based on your kidney function.

OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

The Alberta Serious Incident Response Team (ASIRT) has completed an investigation into the September 2022 death of a ...